CRISPR Therapeutics AG — Form D

CRISPR Therapeutics AG of Zug, V6, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-09. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Simeon GeorgeDirectorRedwood City, CA
Ali BehbahaniDirectorLittleton, CO
Simeon J GeorgeDirectorWayne, PA
Tony HoExecutive OfficerCharlestown, MA
Bradley BolzonDirectorSAN DIEGO, CA
John GreeneDirectorScottsdale, AZ
N. Anthony ColesDirectorBoston, MA
Lawrence KleinExecutive OfficerZug, V8
Rodger NovakDirectorZug, V8
Rodger NovakExecutive OfficerZug, V8
Samarth KulkarniDirectorZug, V8
Samarth KulkarniExecutive OfficerZug, V8
James KasingerExecutive OfficerZug, V8
Katherine HighDirectorZug, V8
Michael TomsicekExecutive OfficerZug, V8
Thomas J WoiwodeDirectorSan Francisco, CA
Kurt J von EmsterDirectorBasel, V8
Sven Ante LundbergExecutive OfficerCambridge, MA
Ali Anthony BehbahaniDirectorBasel, V8
Pablo J CagnoniDirectorBasel, V8
Bradley Anthony BolzonDirectorBasel, V8
Kala Ante SubramanianExecutive OfficerCambridge, MA
Samarth Ante KulkarniExecutive OfficerCambridge, MA
Marc J BeckerExecutive OfficerCambridge, MA
Tyler Ante Dylan-HydeExecutive OfficerCambridge, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2020-04-10D/A$1.0M$1.0M
2016-11-04D$35.0M$35.0M

More